WallStreetZenWallStreetZen

NASDAQ: CPIX
Cumberland Pharmaceuticals Revenue

OverviewEarningsRevenue
DividendOwnership
Cumberland Pharmaceuticals revenue was $36.79M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $9.1M, down 7.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CPIX annual revenue was $39.6M, with -5.9% growth year-over-year.

CPIX past revenue growth

How has CPIX's revenue growth performed historically?

Company
-6.45%
Industry
20.51%
Market
38.67%
CPIX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CPIX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CPIX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CPIX revenue history

Current Revenue
$36.8M
Current Earnings
-$10.9M
Current Profit Margin
-29.6%

Be the first to know when CPIX announces revenue.

CPIX Revenue History By Year

CPIX Yearly RevenueCPIX RevenueCPIX ChangeCPIX Revenue Growth
2023-12-31$39.55M-$2.46M-5.85%
2022-12-31$42.01M$6.03M+16.75%
2021-12-31$35.99M-$1.46M-3.89%
2020-12-31$37.44M$3.05M+8.88%
2019-12-31$34.39M$5.04M+17.19%
2018-12-31$29.34M-$11.81M-28.69%
2017-12-31$41.15M$8.12M+24.60%
2016-12-31$33.03M-$493.49k-1.47%
2015-12-31$33.52M-$3.38M-9.17%
2014-12-31$36.90M$4.87M+15.22%
2013-12-31$32.03M-$16.82M-34.44%
2012-12-31$48.85M-$2.29M-4.48%
2011-12-31$51.14M$5.27M+11.48%
2010-12-31$45.88M$2.34M+5.37%
2009-12-31$43.54M$8.46M+24.13%
2008-12-31$35.08M$7.01M+24.98%
2007-12-31$28.06M$10.25M+57.52%
2006-12-31$17.82MN/AN/A

1 of 2

Cumberland Pharmaceuticals Revenue FAQ

What was CPIX's revenue last quarter?

On Invalid Date, Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 2024 revenue of $9.09 million up 9.92% year over year. In the same quarter last year, Cumberland Pharmaceuticals's revenue was $10.09 million.

What was Cumberland Pharmaceuticals's revenue in 2023?

Cumberland Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2023 was $39.55 million, a 5.85% decrease year over year.

How much does Cumberland Pharmaceuticals make in a day?

Based on Cumberland Pharmaceuticals annual revenue for the past five years, CPIX makes an average of $103,768.73 per day.

What was Cumberland Pharmaceuticals's annual revenue growth in the past year?

As of Q4 2024, Cumberland Pharmaceuticals's revenue has grown -6.45% year over year. This is 26.96 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 20.51%. Cumberland Pharmaceuticals's revenue in the past year totaled $36.79 million.

How much does Cumberland Pharmaceuticals make in a year?

Cumberland Pharmaceuticals's revenue by year for the past five years is:
  • Cumberland Pharmaceuticals's revenue for the twelve months ending Dec 31, 2023 was $39.55 million, a 5.85% decrease year over year.
  • Cumberland Pharmaceuticals's annual revenue for Dec 31, 2022 was $42.01 million, a 16.75% increase from 2021.
  • Cumberland Pharmaceuticals's annual revenue for 2021 was $35.99 million, a 3.89% decrease from 2020.
  • Cumberland Pharmaceuticals's annual revenue for 2020 was $37.44 million, a 8.88% increase from 2019.
  • Cumberland Pharmaceuticals's annual revenue for 2019 was $34.39 million, a 17.19% increase from 2018.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.